Johnson and Johnson Raises Dividend for 64th Consecutive Year

Johnson & Johnson (NYSE:JNJ) declared its 64th consecutive yearly dividend summation connected April 14, 2026, lifting its quarterly payout from $1.30 per stock to $1.34 per share, a 3% increase. The caller dividend is payable June 9, 2026 to shareholders of grounds arsenic of May 26, 2026. For income investors, the rise arrives alongside a existent output of 3.2%, astir treble the healthcare assemblage mean of 1.8%. That operation of output and streak magnitude makes this announcement worthy examining closely.

Six decades of uninterrupted dividend maturation represents a fiscal committedness that has survived recessions, merchandise liability crises, patent cliffs, and a planetary pandemic. Johnson & Johnson has raised its quarterly dividend from $0.46 per stock successful 2008 to $1.34 per stock today, a trajectory that reflects accordant escaped currency travel procreation and a absorption squad that treats dividend maturation arsenic a halfway work to shareholders.

READ: The expert who called NVIDIA successful 2010 just named his apical 10 AI stocks

The caller progression reinforces that pattern. Johnson & Johnson raised its quarterly dividend from $1.19 successful 2023 to $1.24 successful 2024, past to $1.30 successful 2025, and present to $1.34 successful 2026. Each measurement reflects a deliberate, measured attack alternatively than a reactive one. CEO Joaquin Duato framed the broader momentum intelligibly successful the Q1 2026 net release: "Johnson & Johnson had a beardown commencement to 2026 and is delivering connected its committedness for a twelvemonth of accelerated maturation and impact."

At a existent output of 3.2%, Johnson & Johnson offers income investors a instrumentality that exceeds the healthcare assemblage mean of 1.8% by a meaningful margin. That spread matters successful a assemblage wherever galore high-growth names reinvest superior alternatively than instrumentality it. Johnson & Johnson does both. The institution generated $1.5 cardinal successful escaped currency travel successful Q1 2026 alone, providing a wide instauration for the ongoing payout.

Johnson & Johnson besides carries 1 of lone 2 AAA recognition ratings among U.S.-based companies, a favoritism that reflects equilibrium expanse spot good beyond what astir dividend payers tin claim. For investors seeking income with superior preservation characteristics, that recognition illustration adds a furniture of assurance that output figures unsocial cannot convey.